Skip to main content

Hims & Hers Health, Inc. (HIMS) Stock

Hims & Hers Health, Inc. Stock Details, Movements and Public Alerts

Stock Details

Hims & Hers Health, Inc. (HIMS), a prominent company in the healthcare sector within the drug manufacturers - specialty & generic industry, is based in United States and primarily trades on the NYQ.Currently, the stock is trading at $31.33. Over the past 52 weeks, it has ranged between $23.97 and $72.98. This places the current price at 42.9% of its 52-week high and 30.7% above its 52-week low. Recent trading volume was recorded at 15,106,967. The 14-day Relative Strength Index (RSI) stands at 34.55, suggesting neutral conditions. The stock is currently trading below its 50-day moving average of $36.69 by 14.61%. Similarly, it is below its 200-day moving average of $45.76 by 31.53%. The MACD histogram is -0.07, indicating bearish momentum (MACD Line: -1.52, Signal Line: -1.45). The International Securities Identification Number (ISIN) for this stock is US4340772022. There is currently 1 active alert set for HIMS by users.

52-Week Range

$72.98 - $23.97

-57.07% from high · +30.71% from low

Avg Daily Volume

13,479,968

20-day average

100-day avg: 23,374,700

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

59.09

Above market average

Forward P/E

27.88

Earnings expected to grow

Price to Book

12.26

EV/EBITDA

45.32

EPS (TTM)

$0.53

Price to Sales

3.22

Beta

2.37

More volatile than market

Q:How is HIMS valued relative to its earnings and growth?
Hims & Hers Health, Inc. trades at a P/E ratio of 59.09, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 27.88 is lower than the current P/E, indicating analysts expect earnings to grow over the next year.
Q:What is HIMS's risk profile compared to the market?
With a beta of 2.37, Hims & Hers Health, Inc. is significantly more volatile than the market. For every 10% market move, this stock tends to move 24% in the same direction. Higher beta stocks offer greater potential returns but with increased risk. The price-to-book ratio of 12.26 shows investors value the company above its book value, which often reflects intangible assets or growth prospects.

Performance & Growth

Profit Margin

6.05%

Operating Margin

1.97%

EBITDA

$168.09M

Return on Equity

26.21%

Return on Assets

5.54%

Revenue Growth (YoY)

49.20%

Earnings Growth (YoY)

-80.30%

Q:How profitable and efficient is HIMS's business model?
Hims & Hers Health, Inc. achieves a profit margin of 6.05%, meaning it retains $6.05 from every $100 in revenue after all expenses. This relatively low margin suggests the company operates in a competitive environment or high-cost industry where profitability is challenging. The operating margin of 1.97% reveals how efficiently the company runs its core business operations before interest and taxes. With ROE at 26.21% and ROA at 5.54%, the company generates strong returns on invested capital.
Q:What are HIMS's recent growth trends?
Hims & Hers Health, Inc.'s revenue grew by 49.20% year-over-year, representing robust expansion that significantly outpaces typical market growth rates. This strong top-line performance suggests the company is successfully capturing market share or benefiting from favorable industry trends. Earnings decreased by 80.30% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against Drug Manufacturers - Specialty & Generic industry averages for proper context.

Company Size & Market

Market Cap

$7.1B

Revenue (TTM)

$2.21B

Revenue/Share (TTM)

$9.92

Shares Outstanding

219.27M

Book Value/Share

$2.55

Asset Type

EQUITY

Q:What is HIMS's market capitalization and position?
Hims & Hers Health, Inc. has a market capitalization of $7.1B, classifying it as a mid-cap stock ($2B-$10B). Mid-caps often represent companies in their growth phase, offering higher growth potential than large-caps but with more stability than small-caps. They can be attractive takeover targets and may become tomorrow's large-caps. With 219.27M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Drug Manufacturers - Specialty & Generic industry, it competes with other firms in this sector.
Q:How does HIMS's price compare to its book value?
Hims & Hers Health, Inc.'s book value per share is $2.55, while the current stock price is $31.33, resulting in a price-to-book (P/B) ratio of 12.27. This high P/B ratio indicates significant intangible assets, strong brand value, or high growth expectations. Technology and consumer brand companies often trade at elevated P/B ratios due to intellectual property and competitive advantages not reflected on the balance sheet. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$42.69

36.27% upside potential

Analyst Recommendations

Strong Buy

0

Buy

3

Hold

8

Sell

1

Strong Sell

2

Q:How reliable are analyst predictions for HIMS?
14 analysts cover HIMS with 21% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The bearish sentiment could create opportunity if analysts are wrong. The consensus target of $42.69 implies 36.3% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on HIMS?
Current analyst recommendations:03 Buy, 8 Hold, 1 Sell, 2 Strong Sell. The neutral stance suggests uncertainty or fair valuation at current levels.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Jan 15, 2026, 02:12 AM

Technical Indicators

RSI (14-day)

34.55

Neutral

50-Day Moving Average

$36.69

-14.61% below MA-50

200-Day Moving Average

$45.76

-31.53% below MA-200

MACD Line

-1.52

MACD Signal

-1.45

MACD Histogram

-0.07

Bearish

Q:What does HIMS's RSI value tell investors?
The RSI (Relative Strength Index) for HIMS is currently 34.55, indicating the stock is showing bearish momentum (30-40 range). Selling pressure is evident but not extreme. This often occurs during pullbacks in uptrends or early stages of downtrends. Combined with the price being below the 50-day moving average, this confirms bearish conditions.
Q:How should traders interpret HIMS's MACD and moving average crossovers?
MACD analysis shows the MACD line at -1.52 below the signal line at -1.45, with histogram at -0.07. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($36.69) is below the 200-day MA ($45.76), forming a death cross pattern that often warns of extended weakness. Price is currently below both MAs, confirming weakness.

Indicators last updated: Jan 15, 2026, 12:53 AM

Active Alerts

Alert Condition
RSI Threshold Cross
Threshold
30
Created
Dec 29, 2025, 03:33 PM

Stay Ahead of the Market with Hims & Hers Health, Inc. Alerts

Set up price alerts for Hims & Hers Health, Inc. and get notified instantly when the price hits your target. Never miss an important price movement again.